Mark Wills

Mark Wills is a Senior Scientist in New Modalities Process Chemistry at AstraZeneca, focusing on the development of new modality pharmaceuticals from phase II to market launch. They hold an MChem (Hons) degree from Loughborough University and have accumulated experience across various roles in Pharmaceutical Technology and Development, including sustainability, process chemistry, and global project management. Prior to their current position, Mark completed rotations at AstraZeneca as a Global Graduate Associate, and held roles in quality control and product development. Earlier experiences include administrative and supervisory positions in various catering and academic settings.